{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T17:57:05Z","timestamp":1784224625653,"version":"3.55.0"},"reference-count":41,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,10,8]],"date-time":"2021-10-08T00:00:00Z","timestamp":1633651200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["aaojournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ophthalmology"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1016\/j.ophtha.2021.10.009","type":"journal-article","created":{"date-parts":[[2021,10,19]],"date-time":"2021-10-19T22:21:15Z","timestamp":1634682075000},"page":"258-266","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"title":["The Impact of the Coronavirus Disease 2019 Pandemic on Adherence to Ocular Hypotensive Medication in Patients with Primary Open-Angle Glaucoma"],"prefix":"10.1016","volume":"129","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4550-124X","authenticated-orcid":false,"given":"Lyne","family":"Racette","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sampson Listowell","family":"Abu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9678-3019","authenticated-orcid":false,"given":"Shervonne","family":"Poleon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tracy","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nouran","family":"Sabbagh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher A.","family":"Girkin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.ophtha.2021.10.009_bib1","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1111\/irv.12406","article-title":"A\u00a0systematic review of factors affecting intended and actual adherence with antiviral medication as treatment or prophylaxis in seasonal and pandemic flu","volume":"10","author":"Smith","year":"2016","journal-title":"Influenza Other Respir Viruses"},{"issue":"13","key":"10.1016\/j.ophtha.2021.10.009_bib2","doi-asserted-by":"crossref","first-page":"3179","DOI":"10.2147\/RMHP.S265264","article-title":"Implications of COVID-19 infection on medication adherence with chronic therapies in Italy: A proposed observational investigation by the Fail-to-Refill project","author":"Degli Esposti","year":"2020","journal-title":"Risk Manag Healthc Policy"},{"key":"10.1016\/j.ophtha.2021.10.009_bib3","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/j.schres.2020.05.001","article-title":"Long acting injectable antipsychotic medications: ensuring care continuity during the COVID-19 pandemic restrictions","volume":"222","author":"Gannon","year":"2020","journal-title":"Schizophr Res"},{"issue":"7","key":"10.1016\/j.ophtha.2021.10.009_bib4","doi-asserted-by":"crossref","first-page":"2384","DOI":"10.1016\/j.jaip.2020.04.053","article-title":"Changes in medication adherence among patients with asthma and COPD during the COVID-19 pandemic","volume":"8","author":"Kaye","year":"2020","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"issue":"3","key":"10.1016\/j.ophtha.2021.10.009_bib5","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1097\/MLR.0b013e31818afa1c","article-title":"Improving the prediction of medication compliance: the example of bisphosphonates for osteoporosis","volume":"47","author":"Curtis","year":"2009","journal-title":"Med Care"},{"issue":"4","key":"10.1016\/j.ophtha.2021.10.009_bib6","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/S0002-9394(00)00538-9","article-title":"The Advanced Glaucoma Intervention Study (AGIS): 7. The relationship between control of intraocular pressure and visual field deterioration","volume":"130","year":"2000","journal-title":"Am J Ophthalmol"},{"issue":"7","key":"10.1016\/j.ophtha.2021.10.009_bib7","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1001\/jamaophthalmol.2014.856","article-title":"Electronic monitoring to assess adherence with once-daily glaucoma medications and risk factors for nonadherence: the automated dosing reminder study","volume":"132","author":"Boland","year":"2014","journal-title":"JAMA Ophthalmol"},{"issue":"4","key":"10.1016\/j.ophtha.2021.10.009_bib8","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.ophtha.2019.10.022","article-title":"The association between medication adherence and visual field progression in the Collaborative Initial Glaucoma Treatment Study","volume":"127","author":"Newman-Casey","year":"2020","journal-title":"Ophthalmology"},{"issue":"9","key":"10.1016\/j.ophtha.2021.10.009_bib9","first-page":"1138","article-title":"Medication adherence trajectories: a systematic literature review","volume":"26","author":"Alhazami","year":"2020","journal-title":"J\u00a0Manag Care Spec Pharm"},{"issue":"7","key":"10.1016\/j.ophtha.2021.10.009_bib10","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1177\/09612033211004722","article-title":"Medication adherence is influenced by resilience in patients with systemic lupus erythematosus","volume":"30","author":"Mendoza-Pinto","year":"2021","journal-title":"Lupus"},{"issue":"35","key":"10.1016\/j.ophtha.2021.10.009_bib11","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000004761","article-title":"Maladaptive coping strategies and glaucoma progression","volume":"95","author":"Freeman","year":"2016","journal-title":"Medicine (Baltimore)"},{"issue":"1","key":"10.1016\/j.ophtha.2021.10.009_bib12","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1080\/0284186X.2020.1843190","article-title":"Psychosocial determinants of adherence with oral anticancer treatment: \u2018we don\u2019t need no education.\u2019","volume":"60","author":"Kaptein","year":"2021","journal-title":"Acta Oncol"},{"issue":"1","key":"10.1016\/j.ophtha.2021.10.009_bib13","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s12160-014-9641-8","article-title":"Predictors of adherence to glaucoma treatment in a multisite study","volume":"49","author":"Cook","year":"2015","journal-title":"Ann Behav Med"},{"issue":"12","key":"10.1016\/j.ophtha.2021.10.009_bib14","doi-asserted-by":"crossref","first-page":"8086","DOI":"10.1167\/iovs.14-14928","article-title":"Prediction accuracy of a novel dynamic structure-function model for glaucoma progression","volume":"55","author":"Hu","year":"2014","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"5","key":"10.1016\/j.ophtha.2021.10.009_bib15","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1111\/j.1365-2125.2012.04167.x","article-title":"A\u00a0new taxonomy for describing and defining adherence to medications","volume":"73","author":"Vrijens","year":"2012","journal-title":"Br J Clin Pharmacol"},{"issue":"4","key":"10.1016\/j.ophtha.2021.10.009_bib16","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.ajo.2007.06.012","article-title":"Adherence in glaucoma: objective measurements of once-daily and adjunctive medication use","volume":"144","author":"Robin","year":"2007","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2021.10.009_bib17","series-title":"R: a language and environment for statistical computing","year":"2020"},{"key":"10.1016\/j.ophtha.2021.10.009_bib18","first-page":"525","article-title":"Package \u2018segmented.\u2019","volume":"58","author":"Muggeo","year":"2014","journal-title":"Biometrika"},{"issue":"1","key":"10.1016\/j.ophtha.2021.10.009_bib19","first-page":"348","article-title":"Interrupted time series regression for the evaluation of public health interventions: a tutorial","volume":"46","author":"Bernal","year":"2017","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.ophtha.2021.10.009_bib20","first-page":"33","article-title":"Hypothesis testing when a nuisance parameter is present only under the alternative","volume":"74","author":"Davies","year":"1987","journal-title":"Biometrika"},{"issue":"3","key":"10.1016\/j.ophtha.2021.10.009_bib21","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1331\/JAPhA.2013.12065","article-title":"Medication adherence program: adherence challenges and interventions in type 2 diabetes","volume":"53","author":"Odegard","year":"2013","journal-title":"J\u00a0Am Pharm Assoc (2003)"},{"issue":"2","key":"10.1016\/j.ophtha.2021.10.009_bib22","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1002\/da.10113","article-title":"Development of a new resilience scale: the Connor-Davidson resilience scale (CD-RISC)","volume":"18","author":"Connor","year":"2003","journal-title":"Depress Anxiety"},{"key":"10.1016\/j.ophtha.2021.10.009_bib23","series-title":"The Ways of Coping Questionnaire","author":"Folkman","year":"1988"},{"issue":"6","key":"10.1016\/j.ophtha.2021.10.009_bib24","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.jpsychores.2005.10.020","article-title":"The brief illness perception questionnaire","volume":"60","author":"Broadbent","year":"2006","journal-title":"J\u00a0Psychosom Res"},{"issue":"2","key":"10.1016\/j.ophtha.2021.10.009_bib25","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1136\/bjo.2010.199851","article-title":"Validation of a short version of the glaucoma medication self-efficacy questionnaire","volume":"96","author":"Sleath","year":"2012","journal-title":"Br J Ophthalmol"},{"issue":"1","key":"10.1016\/j.ophtha.2021.10.009_bib26","doi-asserted-by":"crossref","first-page":"3652","DOI":"10.1038\/s41467-021-23937-9","article-title":"Effect of COVID-19 response policies on walking behavior in US cities","volume":"12","author":"Hunter","year":"2021","journal-title":"Nat Commun"},{"issue":"3","key":"10.1016\/j.ophtha.2021.10.009_bib27","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1089\/apc.2013.0329","article-title":"Abuse and resilience in relation to HAART medication adherence and HIV viral load among women with HIV in the United States","volume":"28","author":"Dale","year":"2014","journal-title":"AIDS Patient Care STDS"},{"issue":"5","key":"10.1016\/j.ophtha.2021.10.009_bib28","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1080\/13548506.2016.1191658","article-title":"Resilience, religiosity and treatment adherence in hemodialysis patients: a prospective study","volume":"22","author":"Freire de Medeiros","year":"2017","journal-title":"Psychol Health Med"},{"issue":"6","key":"10.1016\/j.ophtha.2021.10.009_bib29","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1016\/j.ophtha.2009.01.021","article-title":"Risk factors for poor adherence to eyedrops in electronically monitored patients with glaucoma","volume":"116","author":"Friedman","year":"2009","journal-title":"Ophthalmology"},{"issue":"8","key":"10.1016\/j.ophtha.2021.10.009_bib30","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1002\/ddr.20484","article-title":"Predictors of medication adherence in patients with rheumatoid arthritis","volume":"72","author":"Salt","year":"2011","journal-title":"Drug Dev Res"},{"issue":"Suppl 2","key":"10.1016\/j.ophtha.2021.10.009_bib31","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1111\/1475-6773.13222","article-title":"Understanding how discrimination can affect health","volume":"54","author":"Williams","year":"2019","journal-title":"Health Serv Res"},{"issue":"5","key":"10.1016\/j.ophtha.2021.10.009_bib32","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1056\/NEJMms2029562","article-title":"Race and genetic ancestry in medicine\u2014a time for reckoning with racism","volume":"384","author":"Borrell","year":"2021","journal-title":"N\u00a0Engl J Med"},{"issue":"2","key":"10.1016\/j.ophtha.2021.10.009_bib33","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0212117","article-title":"Racial and ethnic disparities in medication adherence among privately insured patients in the United States","volume":"14","author":"Xie","year":"2019","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.ophtha.2021.10.009_bib34","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S0039-6257(03)00028-6","article-title":"Primary open-angle glaucoma in blacks: a review","volume":"48","author":"Racette","year":"2003","journal-title":"Surv Ophthalmol"},{"issue":"1","key":"10.1016\/j.ophtha.2021.10.009_bib35","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1016\/j.sapharm.2020.03.015","article-title":"On the frontline against COVID-19: community pharmacists\u2019 contribution during a public health crisis","volume":"17","author":"Cadogan","year":"2021","journal-title":"Res Social Adm Pharm"},{"issue":"1","key":"10.1016\/j.ophtha.2021.10.009_bib36","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1001\/jama.2020.6016","article-title":"Ensuring access to medications in the US during the COVID-19 pandemic","volume":"324","author":"Alexander","year":"2020","journal-title":"JAMA"},{"issue":"10","key":"10.1016\/j.ophtha.2021.10.009_bib37","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1016\/j.ophtha.2015.06.039","article-title":"Patterns of glaucoma medication adherence over four years of follow-up","volume":"122","author":"Newman-Casey","year":"2015","journal-title":"Ophthalmology"},{"issue":"9","key":"10.1016\/j.ophtha.2021.10.009_bib38","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1097\/OPX.0000000000001776","article-title":"Patient and provider perspectives on glaucoma treatment adherence: a Delphi study in urban Alabama","volume":"98","author":"Poleon","year":"2021","journal-title":"Optom Vis Sci"},{"issue":"6","key":"10.1016\/j.ophtha.2021.10.009_bib39","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1177\/1740774515592636","article-title":"A\u00a0comparison of measures used to describe adherence to glaucoma medication in a randomised controlled trial","volume":"12","author":"Cate","year":"2015","journal-title":"Clin Trials"},{"issue":"5","key":"10.1016\/j.ophtha.2021.10.009_bib40","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1177\/0193945911427153","article-title":"Practical and analytic issues in the electronic assessment of adherence","volume":"34","author":"Cook","year":"2012","journal-title":"West J Nurs Res"},{"issue":"8","key":"10.1016\/j.ophtha.2021.10.009_bib41","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1016\/j.jclinepi.2014.12.018","article-title":"Interrupted time series analysis in drug utilization research is increasing: systematic review and recommendations","volume":"68","author":"Jandoc","year":"2015","journal-title":"J\u00a0Clin Epidemiol"}],"container-title":["Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161642021007867?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161642021007867?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T14:11:01Z","timestamp":1758982261000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0161642021007867"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":41,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["S0161642021007867"],"URL":"https:\/\/doi.org\/10.1016\/j.ophtha.2021.10.009","relation":{},"ISSN":["0161-6420"],"issn-type":[{"value":"0161-6420","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Impact of the Coronavirus Disease 2019 Pandemic on Adherence to Ocular Hypotensive Medication in Patients with Primary Open-Angle Glaucoma","name":"articletitle","label":"Article Title"},{"value":"Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ophtha.2021.10.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 by the American Academy of Ophthalmology.","name":"copyright","label":"Copyright"}]}}